Search for in HIV/AIDS Clinical Care
Physician-authored summaries on the latest research on epidemiology, editorials on epidemiology, and perspectives on epidemiology - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 55 results - Relevance
- Date
You searched for: epidemiology in HIV/AIDS
-
Monitoring HIV Patients' Kidney Function in Clinical Practice
- August 3, 2009
- Lynda Anne Szczech, MD, MSCE
- HIV/AIDS
What is known about kidney disease in other clinical contexts can help guide HIV care providers in monitoring the kidney function of their patients. -
PEPFAR in Sub-Saharan Africa: Effects on HIV-Related Outcomes
- June 29, 2009
- Salim S. Abdool Karim, MD, PhD
- HIV/AIDS
An analysis of PEPFAR’s effectiveness in 12 African countries reveals a significant decrease in the number of HIV-related deaths, but not in HIV prevalence.- Reviewing:
- Bendavid E and Bhattacharya J., Ann Intern Med 2009 May 19; 150:688.
-
Should HIV Patients with Opportunistic Infections Receive Immediate ART? Free
- June 22, 2009
- Sonia Nagy Chimienti, MD
- HIV/AIDS
In a randomized trial, the incidence of AIDS progression or death by 48 weeks was significantly lower among patients who received antiretroviral therapy soon after their OI treatment had started than among those for whom ART was delayed.- Reviewing:
- Zolopa AR et al., PLoS One 2009 May 18; 4:e5575.
-
HPV Infection in HIV-Positive MSM
- April 13, 2009
- Sonia Nagy Chimienti, MD
- HIV/AIDS
Infections with human papillomavirus types 16 and 18, which confer high risk for anal cancer, are acquired at high rates among MSM and are slow to clear.- Reviewing:
- de Pokomandy A et al., J Infect Dis 2009 Apr 1; 199:965.
-
HIV and Community-Acquired MRSA Free
- February 9, 2009
- Divya Ahuja, MD, and Helmut Albrecht, MD
- HIV/AIDS
Community-acquired MRSA infections are increasingly common in HIV-positive people. This article summarizes current knowledge regarding risk factors and management of these infections. -
Discordant Responses to ART
- April 18, 2008
- Helmut Albrecht, MD
- HIV/AIDS
Patients who have either complete virologic control or good immunologic recovery, but not both, have higher risk for opportunistic infection or death than do patients who show favorable responses in both parameters.- Reviewing:
- Tan R et al., J Acquir Immune Defic Syndr 2008 Apr 15; 47:553.
-
HIV Transmission by Men Who Have Sex with Men and with Women Free
- November 13, 2006
- G. Sonia Nagy, MD
- HIV/AIDS
Retrospective epidemiologic data from North Carolina support the hypothesis that MSM/W serve as a bridge for infection between MSM and women.- Reviewing:
- Hightow LB et al., Sex Transm Dis 2006 Oct; 33:585-93.
-
Is Community-Acquired MRSA the New Opportunistic Infection of the 21st Century?
- November 30, 2005
- Abigail Zuger, MD
- HIV/AIDS
In a large urban HIV clinic, low CD4-cell count and elevated viral load were among the strongest risk factors for developing MRSA infection.- Reviewing:
- Mathews WC et al., J Acquir Immune Defic Syndr 2005 Oct 1; 40:155-60.
-
Virologic Failure: True or False?
- August 10, 2005
- HIV/AIDS
A 44-year-old man was diagnosed with AIDS after presenting with severe fatigue. His viral load was >750,000 copies/mL, and his CD4 count was 29 cells/mm . . . -
HIV Cases in the U.S. Exceed 1 Million
- July 13, 2005
- HIV/AIDS
CDC officials reported at the National HIV Prevention Conference in June that there are now more than 1 million HIV-infected people in the U.S. — . . . -
Revisiting the Role of Single-Dose Nevirapine for Preventing Perinatal HIV Transmission
- June 15, 2005
- Hoosen Coovadia, MD, Mary Glenn Fowler, MD, MPH, Shahin Lockman, MD, MSc, and James McIntyre, MD
- HIV/AIDS
Single-dose nevirapine is a well-established strategy for preventing mother-to-child transmission (pMTCT) of HIV. This winter, however, media reports cited concerns at the National Institutes of . . . -
New Guidelines on Managing Renal Disease in HIV-Infected Patients
- May 11, 2005
- HIV/AIDS
The HIV Medical Association has provided an up-to-date review on the epidemiology of — and clinical approach to — renal disease in HIV-infected patients. Included . . . -
Report from the 12th Retrovirus Conference
- March 21, 2005
- HIV/AIDS
This year's Retrovirus Conference returned to Boston, and despite predictably wintry weather, the premier scientific HIV meeting again attracted researchers and clinicians from all over . . . -
Revised Guidelines for the Treatment of OIs
- February 1, 2005
- Paul E. Sax, MD
- HIV/AIDS
This revision includes detailed information on 28 infections and on new challenges -- such as immune reconstitution syndromes and drug interactions -- that have arisen since the advent of potent antiretroviral therapy.- Reviewing:
- , MMWR Recomm Rep 2004 Dec 17; 53:1-112.
-
HIV Surveillance among Immigrants and Migrants: Lessons from the EU
- December 1, 2004
- Keith Henry, MD
- HIV/AIDS
This report examines the use of country of origin as a new measure for reporting HIV/AIDS cases in the European Union.- Reviewing:
- Del Amo J et al., AIDS 2004 Sep 24; 18:1867-73.
-
Meeting Report from the XV International AIDS Conference
- September 1, 2004
- HIV/AIDS
The XV International AIDS Conference was held in Bangkok, Thailand from July 11 to 14, under the banner "Access for All." The conference was the . . . -
Anal Cancer in HIV Infection: To Screen or Not to Screen?
- July 1, 2004
- Sue Goldie, MD, MPH, Joel M. Palefsky, MD, and Kimberly Workowski, MD
- HIV/AIDS
Anal cancer screening for HIV-infected patients remains a controversial topic . To discuss the potential risks and benefits of such screening, ACC convened a discussion . . . -
Report from the 11th Conference on Retroviruses and Opportunistic Infections
- April 1, 2004
- HIV/AIDS
Among the highlights were reports on three prospective clinical trials of treatment of hepatitis C in HIV-infected patients, several presentations on investigational entry inhibitors, further descriptions of metabolic complications (but few data on treating these), and perhaps most important, sobering follow-up information on the resistance sequelae of single-dose nevirapine therapy for the prevention of perinatal HIV infection. In the review that follows, the ACC editors focus on the research most likely to have an effect on patient care, either immediately or in the near future. -
HCV Mortality Rates in Coinfected Patients
- October 1, 2003
- G. Sonia Nagy, MD
- HIV/AIDS
In this French survey, 14.3% of deaths among HIV-infected individuals were due to end-stage liver disease in 2001 compared with 1.5% in 1995. -
HIV and Syphilis Coinfection: Trends and Interactions
- February 1, 2003
- Sigall Kassutto, MD, and Paul E. Sax, MD
- HIV/AIDS
Recent reports indicate that syphilis incidence is rising in the U.S. This article reviews the current literature on the epidemiology of syphilis, as well as its clinical manifestations, diagnosis, and treatment in the setting of HIV infection.
Sort by:
Items 1 to 20 of 55 results - Relevance
- Date
